Clinical trials in older, less fit populations: an unmet need?

Affiliations

Comment

Charles E Geyer Jr. Lancet Oncol. 2018 Mar.

. 2018 Mar;19(3):271-272.

doi: 10.1016/S1470-2045(18)30084-6. Epub 2018 Feb 9.

¹ Virginia Commonwealth University, Massey Cancer Center, Richmond, VA 23298-0070, USA. Electronic address: cegeyer@vcu.edu.

No abstract available

Comment on

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
Wildiers H, Tryfonidis K, Dal Lago L, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Altintas S, Touati N, Cardoso F, Brain E. Wildiers H, et al. Lancet Oncol. 2018 Mar;19(3):323-336. doi: 10.1016/S1470-2045(18)30083-4. Epub 2018 Feb 9. Lancet Oncol. 2018. PMID: 29433963 Clinical Trial.